TREM2 and neoplasm: The challenge for future interventions targeting TREM2 lies in how to specifically upregulate TREM2 expression in cardiac or plaque macrophages while avoiding potential side effects in other tissues, such as the harmful anti-inflammatory and immunosuppressive activities of TREM2, which promote tumor growth and immune escape (95–97).